Novozymes and
Chr. Hansen to combine

and create a leading global biosolutions partner

Conference call

A conference call will be hosted on December 12 at 9:00am CET.
The call can be followed live or watched as a replay.

To ask questions, please pre-register here.

Key documents


Notice convening the extraordinary general meeting 2024

Completion of the combination between Novozymes and Chr. Hansen

Retail brochure (in Danish only, January 2024)

All necessary regulatory approvals have been obtained for the combination of Novozymes and Chr. Hansen

Novozymes and Chr. Hansen announce name of future combined company

Conditional competition clearance from the European Commission obtained

Update on merger EC offered remedy proposal

Executive Leadership Team and organizational structure announced for the future combined company of Novozymes and Chr. Hansen

Stock exchange announcement regarding approval of combination by Novozymes shareholders

Investor news on the approval of combination by the Novozymes shareholders and Chr. Hansen shareholders

Press release on the approval of combination by the Novozymes shareholders and Chr. Hansen shareholders 

Investor news on U.S. antitrust regulation

Investor news on Chinese merger approval

Stock exchange announcement regarding exemption document

Stock exchange announcement regarding proposed merger

Press release regarding proposed merger

Exemption document and related documents

Exemption document (for other jurisdictions than Australia)

Exemption document for shareholders of Chr. Hansen Holding A/S residing in Australia 

Retail brochure (in Danish only, March 2023)

Merger documents

Merger plan

Merger statement

Tax-exempt merger ruling

Auditor documents

Valuer’s report on the merger plan

Valuer’s report on the creditors’ position after merger

Extraordinary shareholder’s meeting March 30, 2023

Notice convening the extraordinary general meeting 

Live streaming of extraordinary shareholders’ meeting

Live streaming of extraordinary shareholders’ meeting (in Danish)

Resolutions from extraordinary shareholders’ meeting

Minutes from extraordinary shareholders’ meeting


Investor presentation (December 12, 2022)

Conference call (December 12, 2022)

Other documents

Presentation of the Executive Leadership Team of the future combined company

Draft articles of association for Novozymes after completion of the Merger

Revised remuneration policy

Novozymes Remuneration Report 2022

Novozymes Articles of Association (March 30, 2023)

Novozymes annual reports

The Novozymes Annual Report 2022

The Novozymes Annual Report 2021

The Novozymes Annual Report 2020

The Novozymes Annual Report 2019

Chr. Hansen annual reports

The Chr. Hansen Annual Report 2021/2022

The Chr. Hansen Annual Report 2020/2021

The Chr. Hansen Annual Report 2019/2020



Investor relations

Tobias Cornelius Björklund

Head of Investor relations
+45 3077 8682

Media relations

Lina Danstrup

Head of External Communications
+45 3077 0552